CD4 and type 1 diabetes mellitus: The peptides we used represent consensus immunodominant epitopes recognized by CD4+ T cells in DRB1*0401, DRB1*0301, and DQ8 T1D patients over many published (26, 41–43) and unpublished epitope mapping studies.